Dendreon Corp (DNDN) financial statements (2021 and earlier)

Company profile

Business Address 1301 2ND AVE.
SEATTLE, WA 98101
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments180354
Cash and cash equivalents93188
Short-term investments87165
Receivables3539
Inventory, net of allowances, customer advances and progress billings5476
Inventory5476
Prepaid expense and other current assets18
Other undisclosed current assets151
Total current assets:284487
Noncurrent Assets
Property, plant and equipment125151
Long-term investments and receivables2076
Long-term investments2076
Other noncurrent assets6
Prepaid expense and other noncurrent assets7
Total noncurrent assets:151234
TOTAL ASSETS:434721
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6485
Accounts payable1013
Accrued liabilities3445
Employee-related liabilities2027
Debt304
Deferred revenue and credits78
Other undisclosed current liabilities37
Total current liabilities:104104
Noncurrent Liabilities
Long-term debt and lease obligation563567
Long-term debt, excluding current maturities559560
Capital lease obligations46
Liabilities, other than long-term debt55
Accounts payable and accrued liabilities55
Total noncurrent liabilities:568572
Total liabilities:672676
Stockholders' equity
Stockholders' equity attributable to parent(248)35
Common stock00
Additional paid in capital2,0031,989
Accumulated other comprehensive income00
Accumulated deficit(2,251)(1,954)
Total stockholders' equity:(248)35
Other undisclosed liabilities and equity1011
TOTAL LIABILITIES AND EQUITY:434721

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues284326
Revenue, net284325
Cost of revenue(166)(228)
Cost of goods and services sold(46) 
Gross profit:11798
Operating expenses(527)(665)
Other undisclosed operating income166228
Operating loss:(243)(340)
Nonoperating income (expense)(0)0
Investment income, nonoperating(2)(2)
Interest and debt expense(54)(55)
Other undisclosed income from continuing operations before equity method investments, income taxes 1
Net loss:(297)(394)
Other undisclosed net income attributable to parent1 
Net loss available to common stockholders, diluted:(297)(394)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net loss:(297)(394)
Other comprehensive income (loss)(0)0
Comprehensive loss:(298)(393)
Other undisclosed comprehensive income, net of tax, attributable to parent1 
Comprehensive loss, net of tax, attributable to parent:(297)(393)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: